Gene · 3416
Papers2,652
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,652
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Current biomarkers and treatment strategies in Alzheimer disease: An overview and future perspectives. | IBRO Neurosci Rep | 2024 | 38169888 | PubTator, text mining | PubMed |
| Histone acetylation in an Alzheimer's disease cell model promotes homeostatic amyloid-reducing pathways. | Acta Neuropathol Commun | 2024 | 38167174 | PubTator, text mining | PubMed |
| Metal interference screw fixation combinations show high revision rates in primary hamstring tendon ACL reconstruction. | BMC Musculoskelet Disord | 2024 | 38166808 | PubTator, text mining | PubMed |
| Ginsenoside Rg1 promotes β‑amyloid peptide degradation through inhibition of the ERK/PPARγ phosphorylation pathway in an Alzheimer's disease neuronal model. | Exp Ther Med | 2024 | 38125359 | PubTator, text mining | PubMed |
| Polysaccharide from Polygala tenuifolia alleviates cognitive decline in Alzheimer's disease mice by alleviating Aβ damage and targeting the ERK pathway. | J Ethnopharmacol | 2024 | 38081400 | PubTator, text mining | PubMed |
| Effects of DHA (omega-3 fatty acid) and estradiol on amyloid β-peptide regulation in the brain. | Brain Res | 2024 | 37992797 | PubTator, text mining | PubMed |
| Correlations between insulin-degrading enzyme and metabolic markers in patients diagnosed with type 2 diabetes, Alzheimer's disease, and healthy controls: a comparative study. | Endocrine | 2024 | 37980298 | PubTator, text mining | PubMed |
| Neprilysin inhibitors and risk of Alzheimer's disease: A future perspective. | J Cell Mol Med | 2024 | 37847125 | PubTator, text mining | PubMed |
| Autophagy in neural stem cells and glia for brain health and diseases. | Neural Regen Res | 2024 | 37843206 | PubTator, text mining | PubMed |
| Angiotensin Receptor Blockers and Cognition: a Scoping Review. | Curr Hypertens Rep | 2024 | 37733162 | PubTator, text mining | PubMed |
| Polyoxidovanadates a new therapeutic alternative for neurodegenerative and aging diseases. | Neural Regen Res | 2024 | 37721286 | PubTator, text mining | PubMed |
| Alzheimer's Disease Puzzle: Delving into Pathogenesis Hypotheses. | Aging Dis | 2024 | 37450931 | PubTator, text mining | PubMed |
| Amyloid Precursor Protein: A Regulatory Hub in Alzheimer's Disease. | Aging Dis | 2024 | 37307834 | PubTator, text mining | PubMed |
| Role of Oxidative Stress, Methionine Oxidation and Methionine Sulfoxide Reductases (MSR) in Alzheimer's Disease. | Antioxidants (Basel) | 2023 | 38275641 | PubTator, text mining | PubMed |
| Genetic contributions to risk of adverse pregnancy outcomes. | Curr Cardiovasc Risk Rep | 2023 | 38186860 | PubTator, text mining | PubMed |
| An Appraisal of the Oleocanthal-Rich Extra Virgin Olive Oil (EVOO) and Its Potential Anticancer and Neuroprotective Properties. | Int J Mol Sci | 2023 | 38139152 | PubTator, text mining | PubMed |
| The Role of Cdc42 in the Insulin and Leptin Pathways Contributing to the Development of Age-Related Obesity. | Nutrients | 2023 | 38068822 | PubTator, text mining | PubMed |
| The weight-adjusted-waist index and cognitive impairment among U.S. older adults: a population-based study. | Front Endocrinol (Lausanne) | 2023 | 38027119 | PubTator, text mining | PubMed |
| Synthesis of Pyrrolo[3,4-b]pyridin-5-ones via Ugi-Zhu Reaction and In Vitro-In Silico Studies against Breast Carcinoma. | Pharmaceuticals (Basel) | 2023 | 38004428 | PubTator, text mining | PubMed |
Screening of Crucial Cytosolicproteins Interconnecting the Endoplasmic Reticulum and Mitochondria in Parkinson's Disease and the Impact of Anti-Parkinson Drugs in the Preservation of Organelle Connectivity. | Brain Sci | 2023 | 38002511 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3416/papers?page=6